SecBot SecBot
6-K ·Filed Oct 26, 2026

BWAY

Brainsway Ltd.
NEUTRAL
Impact 3/10
Processed1h 37m ago SEC0001171843-26-006807
Notable filing: 6-K

Price Chart

Loading chart...

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001171843-26-006807
Document: f6k_102526.htm0001171843-26-006807
Document: 0001171843-26-006807-index-headers.html0001171843-26-006807
Document: 0001171843-26-006807-index.html0001171843-26-006807
Document: 0001171843-26-006807.txt0001171843-26-006807
20 reports for BWAY
Performance horizon
57% Hit rate @ T+60 4 of 7 directional calls Went positive at some point 8 of 11 best @ T+60▲ +27.55%Mar 4, 2026
Filters
Rows
Reports for BWAY — sortable, filterable
TypeNow
Oct 26, 2026
today
6-K
NEUTRAL ★ 3/10
—awaiting T+60——
Oct 21, 2026
4d ago
6-K
NEUTRAL ★ 3/10
$11.44awaiting T+60—$11.25 (−1.66%)
Oct 19, 2026
6d ago
6-K
NEUTRAL ★ 3/10
$11.99awaiting T+60—$11.25 (−6.17%)
Oct 19, 2026
7d ago
Press Release
NEUTRAL ★ 4/10
$11.99awaiting T+60—$11.25 (−6.17%)
Oct 13, 2026
13d ago
6-K
NEUTRAL ★ 4/10
$11.92awaiting T+60—$11.25 (−5.62%)
Sep 8, 2026
6w ago
6-K
NEUTRAL ★ 4/10
$14.16awaiting T+60—$11.25 (−20.55%)
Aug 27, 2026
8w ago
6-K
BULLISH ★ 6/10
$14.40awaiting T+60—$11.25 (−21.88%)
Aug 12, 2026
10w ago
6-K
BULLISH ★ 6/10
$16.47awaiting T+60—$11.25 (−31.69%)
Aug 12, 2026
10w ago
6-K
BULLISH ★ 7/10
$16.60awaiting T+60—$11.25 (−32.23%)
Aug 12, 2026
10w ago
Press Release
BULLISH ★ 7/10
$16.60awaiting T+60—$11.25 (−32.23%)
Showing 10 of 20

US Market Status

Market Closed — Opens in 21m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 26, 2026

Fresh BWAY Intelligence

Analysis is for subscribers only.

BrainsWay announced that U.S. insurance coverage for its Deep TMS treatment of OCD has expanded to over 118 million covered lives. The press release contains no financial figures, revenue data, or guidance; it is a reimbursement milestone update with forward-looking statements only.

Subscribe for Full Access